Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001213900-14-008245
Filing Date
2014-11-14
Accepted
2014-11-14 16:11:47
Documents
4
Period of Report
2014-12-22
Effectiveness Date
2014-11-14

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT def14a1114_actinium.htm DEF 14A 516267
2 GRAPHIC image_001.jpg GRAPHIC 3765
3 GRAPHIC image_003.jpg GRAPHIC 3765
4 GRAPHIC image_004.jpg GRAPHIC 3802
  Complete submission text file 0001213900-14-008245.txt   533430
Mailing Address 546 5TH AVENUE, 14TH FLOOR NEW YORK NY 10036
Business Address 546 5TH AVENUE, 14TH FLOOR NEW YORK NY 10036 212-300-2131
Actinium Pharmaceuticals, Inc. (Filer) CIK: 0001388320 (see all company filings)

EIN.: 880378336 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36374 | Film No.: 141224240
SIC: 2834 Pharmaceutical Preparations